BC FINANCE
Saved by @SteveeRogerr

#Global #ETF Weekly (thread): 15 Jan 2021

- 2020 worst perf #sector making comeback in 2021 $IXC

- This is helping #oil producing countries with #Nigeria, #UAE & #Russia in top5 #Country ETF YTD performers in USD $NGE $UAE $ERUS

- Few countries moving in red this week

 2/8

#Global #Value #stocks still making short-term recovery, with $IWVL #ETF still looking very strong relatively over the short-term. Over 3yr period it is however still lagging quite substantially.

This should be interesting for this months #OrbisvsSP500 unofficial challenge
3/8

This one is worrying, but then again, it's been for some time. #Global #Tech #stocks relative to #MSCI All Country World Index is definitely creating some concern. Be very careful.

$IXN vs $ACWI
4/8

Know this one might create some controversy, therefore disclaimer 1st. I'm also not positive on #US #Bonds over longer-term. But be careful over short-term as $TLT #ETF relative to $SPY indicate oversold (bonds) &/or overbought (equities) & could see profit taking. #stimulus
5/8

This 👆🏼 could be positive for #Gold. Comparing $GLD (gold price) #ETF with $GDX (#Goldminers), one can see that miners getting close to gold ($/oz). Relative not cheap yet & can still see further weakness. Will do separate tech tweet on GDX later. In short wait for $32.20.
6/8

Back to #Bonds. #EmergingMarkets Government Bonds still lagging #Global Government Bonds. Yield seekers might use possible 'risk-on' environment to start buying EM bonds.

$EMB vs $IGLO
7/8

#Global #Financials #ETF, very similar to #Value ETF, are making quite the comeback relative to #MSCI All Country World Index. Still however have a MASSIVE gap to fill, which could take some time. IMHO, it's still an opportunity.

$IXG vs $ACWI
8/8

And then finally, #EmergingMarkets #ETF still storming ahead against #DevelopedMarkets ETF, still not relatively "overbought" yet, but getting close.

#SouthAfrica however still lagging in 2021, with $EZA YTD performance in USD of +0.2% vs DM's $URTH +1% & EM's +5.2%.
Unroll @threadreaderapp

More from Finance

Investment Books
Investment Books
@InvestmentBook1
Thread Best books recommendation by one of best investor I knew @insharebazaar (Virtually)

He grab many multibagger stocks and His style also unique(1st Seen interview in @TraderHarneet's YT Channel)

He follow Simple process

Young Intelligent Investor who also appeared in ET

1. One Up On Wall Street

2. Rich Dad Poor Dad

Access here : https://t.co/UWOCF732z6


3. The Unusual Billionaires

4. Trading in the Zone

https://t.co/G7mqVPtEM0


5. Market Wizards

6. The Intelligent Investor

https://t.co/yPKBzYyPAl


7. The Five Rules for Successful Stock Investing

8. Reminiscences of a Stock Operator

https://t.co/PiioB3hdHP
FINANCE
Shuchi Nahar
Shuchi Nahar
@shuchi_nahar
To understand Financial Shenanigans & detect accounting manipulations from Annual Reports with checklist
In detail and lucid terms

Financial Shenanigans
(Part-1)
https://t.co/wa6HSElug0

(Part-2)
https://t.co/Vrva17GvgP

(Part-3)
https://t.co/XuziOCDHL2

@dmuthuk @ms89_meet
FINANCE , ACCOUNTING AMP FINANCIAL STATEMENTS
Advertisement
Eric Feigl-Ding
Eric Feigl-Ding
@DrEricDing
ATROCIOUS big pharma price gouging of insulin:

This crying mother can’t afford the $1000 for her son’s insulin.

📌yet, it only costs pharma $5 to produce.

📌Insulin was invented 100 years ago by Fred Banting—who donated patent for $1 to make it free for all.

Let that sink in.


2) Insulin is one of the most disgusting cases of price gouging ever.

America has long taken a free market approach to pharmaceuticals.
Drug companies haggle separately over drug prices with a variety of private insurers across the

3) “Meanwhile, Medicare, the government health program for those over age 65 — it’s also the nation’s largest buyer of drugs—is barred from negotiating drug prices. That gives pharma more leverage, and it leads to the kind of price surges of EpiPens, opioid antidotes, & insulin.”

4) In 2018:
Johnson & Johnson CEO made $30M
Pfizer CEO made $28M
Merck CEO made $18M
Eli Lilly CEO made $16M
Gilead CEO made $16M

Meanwhile:

📌Americans spent $535B on Rx drugs

📌1/4 of diabetics rationed insulin to survive

📌500K Americans went bankrupt from medical bills.

5) What’s the right price patients should pay for medications? ZERO dollars, because no copay ==> more patients get their medicine ==> saves lives and saves money. Copays decrease adherence, and copays hurt patients who actually need them.
FINANCE
Ilhan Omar
Ilhan Omar
@IlhanMN
As a young immigrant, I took out thousands of dollars in debt to go to for-profit college—thinking it was part of the American Dream.

Like millions of Americans, I was left deeply in debt with a worthless degree and shoddy education. #CancelStudentDebt

I was fortunate enough to eventually go to a public university and begin to pay it off, but millions do not have that luxury.

Here are some misconceptions about who has debt and why we need full cancellation.

Is this really a crisis?

Yes! Student debt has more than doubled in just 10 years. 45 million Americans now are saddled with over $1.7 trillion in debt—and the delinquency rates have nearly doubled.

Isn’t it already cancelled during the pandemic?

Student loan interest is on hold during the pandemic—but the debt is not forgiven. That means millions will owe thousands of dollars in backpay if that debt isn’t relieved.

Does President Biden have the authority to end the crisis?

Yes! The federal government owns 92% of the $1.7 trillion in student debt. Biden can forgive it with the stroke of a pen.
FINANCE
Intrinsic Compounding
Intrinsic Compounding
@soicfinance
@nivin27 Kenneth Andrade & all his interviews ever
FINANCE

You May Also Like

Jaya_Upadhyaya
Jaya_Upadhyaya
@Jayalko1
AHOBILAM NARASIMHA SWAMY KSHETRAM: KURNOOL (AP)
#andhratemples

Ahobilam is the place where Prabhu appears in his fierce form, called Ugra Narasimha, who is Svayambhu (self-manifest).
Ahobilam is one of the 108 Divya Desams. It has 9 shrines for different forms of Narsimha.


Ahobilam was the exact place where Sri Narasimha appeared and tore apart Hiranyakashipu to save Prahlad. At that moment, all the Devas appeared and praised him as Ahobala (Aho is mighty and bala is strength). So the place came to be called Ahobilam.


Out of the 9 shrines, most famous is the Ahobila Narasimha Swamy where Prabhu is seen as Ugra Narasimha.
In another shrine, Prabhu appears as Malola Narasimha Swamy. Malola means beloved of Lakshmi. Here Prabhu is in peaceful mudra with his consort Ma ChenchuLakshmi.


Jwala Narasimha Swamy shrine is the actual spot where the fierce anger of Prabhu reached its culmination when he tore Hiranyakasipu.

Ugra Stambham is the pillar from which Narasimha appeared with such force that the entire hill split into two.
ALL
\u0b85\u0bb8\u0bcd\u0ba4\u0bbf\u0ba9\u0bbe\u0baa\u0bc1\u0bb0\u0ba4\u0bcd\u0ba4\u0bc1 \u0b85\u0bb0\u0b9a\u0bbf\U0001f478
அஸ்தினாபுரத்து அரசி👸...
@SivaRoobini555
#தினம்_ஒரு_திருவாசகம்
தொல்லை இரும்பிறவிச் சூழும் தளை நீக்கி
அல்லல் அறுத்து ஆனந்தம் ஆக்கியதே – எல்லை
மருவா நெறியளிக்கும் வாதவூர் எங்கோன்
திருவாசகம் என்னும் தேன்

பொருள்:
1.எப்போது ஆரம்பித்தது என அறியப்படமுடியாத தொலை காலமாக (தொல்லை)

2. இருந்து வரும் (இரும்)


3.பிறவிப் பயணத்திலே ஆழ்த்துகின்ற (பிறவி சூழும்)

4.அறியாமையாகிய இடரை (தளை)

5.அகற்றி (நீக்கி),

6.அதன் விளைவால் சுகதுக்கமெனும் துயரங்கள் விலக (அல்லல் அறுத்து),

7.முழுநிறைவாய்த் தன்னுளே இறைவனை உணர்த்துவதே (ஆனந்த மாக்கியதே),

8.பிறந்து இறக்கும் காலவெளிகளில் (எல்லை)

9.பிணைக்காமல் (மருவா)

10.காக்கும் மெய்யறிவினைத் தருகின்ற (நெறியளிக்கும்),

11.என் தலைவனான மாணிக்க வாசகரின் (வாதவூரெங்கோன்)

12.திருவாசகம் எனும் தேன் (திருவா சகமென்னுந் தேன்)

முதல்வரி: பிறவி என்பது முன்வினை விதையால் முளைப்பதோர் பெருமரம். அந்த ‘முன்வினை’ எங்கு ஆரம்பித்தது எனச் சொல்ல இயலாது. ஆனால் ‘அறியாமை’ ஒன்றே ஆசைக்கும்,, அச்சத்துக்கும் காரணம் என்பதால், அவையே வினைகளை விளைவிப்பன என்பதால், தொடர்ந்து வரும் பிறவிகளுக்கு, ‘அறியாமையே’ காரணம்

அறியாமைக்கு ஆரம்பம் கிடையாது. நமக்கு ஒரு பொருளைப் பற்றிய அறிவு எப்போதிருந்து இல்லை? அதைச் சொல்ல முடியாது. அதனாலேதான் முதலடியில், ஆரம்பமில்லாத அஞ்ஞானத்தை பிறவிகளுக்குக் காரணமாகச் சொல்லியது. ஆனால் அறியாமை, அறிவின் எழுச்சியால், அப்போதே முடிந்து விடும்.
ALL
Advertisement
Laurie Voss
Laurie Voss
@seldo
The 2018 State of JavaScript survey is out. They got 20,000 responses and have some delicious, delicious data. I'mma thread in some highlights:

First up: JavaScript flavors. There's TypeScript at 47% adoption, a tad higher than npm's own survey results (which said 46%). npm's survey is coming up again soon and will ask about TypeScript in a lot more detail.


I really, *really* like SoJ's "would not use again" question, which lets people who've abandoned a tech self-identify. This is noticeable in the graph above with Flow users -- 41% of people who've used Flow say they wouldn't use it again.

Now JavaScript frameworks. It's been a full year since npm's survey, so these numbers differ from ours in the directions I expected:
React 65% (vs. 60%)
Vue 29% (vs. 24%)
Ember 5% (vs 4%, I was expecting a bigger rise)

But there's a shocker in here: Angular.


npm's survey had Angular at 40% last year and SoJ has it at either:
- 58% (if you include those who don't want to use it again)
- 24% (if you count only those who like it)
Since npm's question didn't ask if they intend to *continue* using it I think that might explain this.
TECH
Erik Torenberg
Erik Torenberg
@eriktorenberg
1/ Here’s a list of conversational frameworks I’ve picked up that have been helpful.

Please add your own.

2/ The Magic Question: "What would need to be true for you


3/ On evaluating where someone’s head is at regarding a topic they are being wishy-washy about or delaying.

“Gun to the head—what would you decide now?”

“Fast forward 6 months after your sabbatical--how would you decide: what criteria is most important to you?”

4/ Other Q’s re: decisions:

“Putting aside a list of pros/cons, what’s the *one* reason you’re doing this?” “Why is that the most important reason?”

“What’s end-game here?”

“What does success look like in a world where you pick that path?”

5/ When listening, after empathizing, and wanting to help them make their own decisions without imposing your world view:

“What would the best version of yourself do”?
LIFE
Suhas S. Hardutt
Suhas S. Hardutt
@HarduttSuhas
Marvels of Medical Science in Ancient India

ACHARYA SUSHRUTA and SUSHRUTA SAMHITA

Ancient Indians were pioneers in diverse fields of study and their genius was centuries ahead of their times. Feel the glory, basking in pride of their unparalleled achievements.

(Thread)


Sushruta (circa 7th or 6th century BC) was a surgeon who in present times is known as the “father of Indian medicine” and “father of plastic surgery” for inventing and developing surgical procedures. He lived in Kashi on the banks of river Ganga.(1)

His work documented in the Sushruta Samhita (compendium) is one of the oldest texts in the world on plastic surgery and regarded as one of the trilogies of Ayurveda. The other 2 being the Charaka Samhita and Astanga Hridaya.(2)

Sushruta compiled the Sushruta Samhita as an instruction manual for physicians to treat patients.(3)

The Samhita caters to surgical techniques listing over 300 surgical procedures and 120 surgical instruments. Additionally to 1,120 diseases, injuries and their treatments with over 700 medicinal herbs and their application.(4)
RELIGION